Vivos Inc. (RDGL)
USD 0.12
(-2.79%)
USD 0.12
(-2.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.89 Million USD | -19.49% |
| 2022 | -2.42 Million USD | 5.11% |
| 2021 | -2.55 Million USD | -105.16% |
| 2020 | -1.24 Million USD | 33.5% |
| 2019 | -1.87 Million USD | 75.7% |
| 2018 | -7.7 Million USD | -20.01% |
| 2017 | -6.41 Million USD | 34.87% |
| 2016 | -9.85 Million USD | -258.12% |
| 2015 | 6.23 Million USD | 134.42% |
| 2014 | -18.1 Million USD | -421.74% |
| 2013 | -3.47 Million USD | 59.58% |
| 2012 | -8.58 Million USD | -212.27% |
| 2011 | -2.74 Million USD | 32.19% |
| 2010 | -4.05 Million USD | -1.58% |
| 2009 | -3.99 Million USD | 35.18% |
| 2008 | -6.15 Million USD | -114.64% |
| 2007 | -2.86 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -558.53 Thousand USD | 48.1% |
| 2024 Q2 | -503.45 Thousand USD | 9.86% |
| 2023 Q2 | -902.52 Thousand USD | -21.65% |
| 2023 FY | -2.89 Million USD | -19.49% |
| 2023 Q3 | -667.69 Thousand USD | 26.02% |
| 2023 Q4 | -1.07 Million USD | -61.19% |
| 2023 Q1 | -741.88 Thousand USD | -117.07% |
| 2022 Q1 | -652.31 Thousand USD | -266.0% |
| 2022 FY | -2.42 Million USD | 5.11% |
| 2022 Q4 | 4.34 Million USD | 1668.33% |
| 2022 Q3 | -277.06 Thousand USD | 64.82% |
| 2022 Q2 | -787.53 Thousand USD | -20.73% |
| 2021 FY | -2.55 Million USD | -105.16% |
| 2021 Q1 | -288.18 Thousand USD | 4.6% |
| 2021 Q2 | -1.86 Million USD | -545.47% |
| 2021 Q3 | -201.16 Thousand USD | 89.19% |
| 2021 Q4 | -178.23 Thousand USD | 11.4% |
| 2020 Q2 | -159.08 Thousand USD | 55.84% |
| 2020 Q4 | -302.08 Thousand USD | -122.79% |
| 2020 Q1 | -360.23 Thousand USD | 28.53% |
| 2020 FY | -1.24 Million USD | 33.5% |
| 2020 Q3 | -135.59 Thousand USD | 14.77% |
| 2019 FY | -1.87 Million USD | 75.7% |
| 2019 Q3 | -669.37 Thousand USD | -234.18% |
| 2019 Q4 | -504.03 Thousand USD | 24.7% |
| 2019 Q1 | -236.38 Thousand USD | -100.9% |
| 2019 Q2 | -200.3 Thousand USD | 15.26% |
| 2018 Q2 | -6.01 Million USD | -567.12% |
| 2018 Q3 | -26.91 Million USD | -347.65% |
| 2018 FY | -7.7 Million USD | -20.01% |
| 2018 Q4 | 26.12 Million USD | 197.07% |
| 2018 Q1 | -901.18 Thousand USD | 65.67% |
| 2017 Q3 | -1.85 Million USD | -22.36% |
| 2017 FY | -6.41 Million USD | 34.87% |
| 2017 Q4 | -2.62 Million USD | -41.24% |
| 2017 Q2 | -1.51 Million USD | -264.42% |
| 2017 Q1 | -416.76 Thousand USD | -244.07% |
| 2016 Q2 | -4.18 Million USD | 27.95% |
| 2016 FY | -9.85 Million USD | -258.12% |
| 2016 Q4 | 289.27 Thousand USD | 285.45% |
| 2016 Q3 | -155.98 Thousand USD | 96.27% |
| 2016 Q1 | -5.8 Million USD | -1037.06% |
| 2015 Q3 | -2.53 Million USD | -138.52% |
| 2015 FY | 6.23 Million USD | 134.42% |
| 2015 Q2 | 6.56 Million USD | 317.16% |
| 2015 Q1 | 1.57 Million USD | 110.55% |
| 2015 Q4 | 619.58 Thousand USD | 124.48% |
| 2014 Q1 | -1.08 Million USD | 13.1% |
| 2014 FY | -18.1 Million USD | -421.74% |
| 2014 Q2 | -1.23 Million USD | -14.08% |
| 2014 Q4 | -14.92 Million USD | -1621.59% |
| 2014 Q3 | -866.78 Thousand USD | 29.87% |
| 2013 Q2 | -663.64 Thousand USD | -9.6% |
| 2013 FY | -3.47 Million USD | 59.58% |
| 2013 Q1 | -605.51 Thousand USD | 84.74% |
| 2013 Q4 | -1.24 Million USD | -30.57% |
| 2013 Q3 | -954.87 Thousand USD | -43.88% |
| 2012 Q1 | -1.15 Million USD | -50.34% |
| 2012 FY | -8.58 Million USD | -212.27% |
| 2012 Q4 | -3.96 Million USD | -67.99% |
| 2012 Q3 | -2.36 Million USD | -114.53% |
| 2012 Q2 | -1.1 Million USD | 4.46% |
| 2011 Q1 | -753.26 Thousand USD | 24.48% |
| 2011 Q2 | -631.52 Thousand USD | 16.16% |
| 2011 Q3 | -598.02 Thousand USD | 5.3% |
| 2011 Q4 | -766.8 Thousand USD | -28.22% |
| 2011 FY | -2.74 Million USD | 32.19% |
| 2010 Q1 | -1.23 Million USD | -39.7% |
| 2010 FY | -4.05 Million USD | -1.58% |
| 2010 Q3 | -1.18 Million USD | -83.61% |
| 2010 Q4 | -997.49 Thousand USD | 15.57% |
| 2010 Q2 | -643.5 Thousand USD | 47.79% |
| 2009 FY | -3.99 Million USD | 35.18% |
| 2009 Q4 | -882.22 Thousand USD | 12.12% |
| 2009 Q3 | -1 Million USD | -34.69% |
| 2009 Q2 | -745.36 Thousand USD | 45.21% |
| 2009 Q1 | -1.36 Million USD | 43.26% |
| 2008 Q1 | -1.46 Million USD | 0.0% |
| 2008 Q4 | -2.39 Million USD | -125.26% |
| 2008 Q2 | -1.72 Million USD | -17.22% |
| 2008 Q3 | -1.06 Million USD | 38.15% |
| 2008 FY | -6.15 Million USD | -114.64% |
| 2007 FY | -2.86 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -300.485% |
| IR-Med Inc. | -4.9 Million USD | 41.032% |
| Polarean Imaging plc | -11.88 Million USD | 75.643% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 833.146% |
| Avitar, Inc. | -2.25 Million USD | -28.107% |
| AVITA Medical, Inc. | -39.16 Million USD | 92.609% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -148.477% |
| Össur hf. | 58.38 Million USD | 104.958% |
| Zecotek Photonics Inc. | -3.51 Million USD | 17.739% |
| QHSLab, Inc. | -468.36 Thousand USD | -518.059% |
| Wellstar International, Inc. | -3.1 Million USD | 6.875% |
| Össur hf. | 58.38 Million USD | 104.958% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 223.076% |
| Escalon Medical Corp. | -125.26 Thousand USD | -2210.977% |
| Aurora Spine Corporation | -1.68 Million USD | -72.249% |
| BrainsWay Ltd. | -4.19 Million USD | 31.028% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 74.82% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -376.878% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.394% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -1225.006% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -62.824% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -592.47% |
| Nanomix Corporation | -12.33 Million USD | 76.528% |
| Theraclion SA | -3.67 Million USD | 21.231% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -284.439% |
| Positron Corporation | -1.63 Million USD | -76.649% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | -9.598% |
| Lombard Medical, Inc. | -31.03 Million USD | 90.673% |
| ALR Technologies Inc. | -11.89 Million USD | 75.668% |
| Stratec SE | 14.42 Million USD | 120.066% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -4053.697% |
| Heart Tronics, Inc. | -13.32 Million USD | 78.279% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -2206.098% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 79.376% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 88.783% |
| VMS Rehab Systems, Inc. | 46.44 USD | 6233418.26% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 17.032% |
| Ingen Technologies, Inc. | -5.06 Million USD | 42.808% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -219.59% |
| United American Healthcare Corporation | 723 Thousand USD | 500.381% |
| ECGI Holdings, Inc. | -3.61 Million USD | 19.833% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -339.916% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -303.815% |
| Urologix, Inc. | -7.6 Million USD | 61.951% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -70.903% |
| Nexeon MedSystems Inc. | -2.17 Million USD | -32.931% |
| SS Innovations International, Inc. | -20.94 Million USD | 86.177% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -259.587% |
| Smith & Nephew plc | 263 Million USD | 101.101% |
| NIOX Group Plc | 13.64 Million USD | 121.222% |
| Fuse Medical, Inc. | 1.45 Million USD | 298.276% |
| Broncus Holding Corporation | -28.09 Million USD | 89.695% |
| Brain Scientific Inc. | -12.34 Million USD | 76.549% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 90.125% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -1706.421% |